药学专硕

卢志远

2026年03月25日

姓名:卢志远

硕士生导师,博士后合作导师,泰山学者青年专家,山东高校青创团队负责人

职称:副教授

联系方式:luzhiyuan@sdfmu.edu.cn;lzy520406@163.com


研究方向:

1. 炎症免疫、神经退行性等疾病中药活性成分发现

2. 中药活性成分靶点鉴定以及分子药理机制研究

3. 中药碳点等超分子化学生物学


主要学术任职:

1. 中国药理学会生化与分子药理学专业委员会青年委员

2. 中国中西医结合学会中药专委会青年委员

3. 山东省研究型医院协会杰出青年学者分会常务委员

4. 中国民族医药学会方药量效研究分会理事

5. 中国中医药研究促进会免疫疾病分会委员

6. 山东中医药学会中医基础理论专业委员会委员

7. Journal of Ginseng Research杂志副主编(中科院小类1区,IF:6.7)

8. IMed、Scientific Reports、Chinese Medicine、Med Research、Acta Materia Medica、International Journal of Cell Biology、EngMedicine、Traditional Medicine Research、Science of Traditional Chinese Medicine、Pharmaceutical Science Advances、Pharmacology Discovery和《中医药研究进展 》等杂志青年编委


主要获奖情况(包括作为指导教师):

1. 2025年,山东省医学会医学科技进步青年奖三等奖

2. 2025年,山东省中药协会青年人才奖

3. 2025年,全国大学生药苑论坛,创新成果三等奖,指导教师

4. 2025年国家级大学生创新创业训练计划项目,指导教师

主持科研课题:

1. 山东省泰山学者青年专家,2025.01-2027.12,75万,在研。

2. 国家自然科学基金青年项目,32300957,磷酸酶PPM1B调控巨噬细胞M1型极化介导溃疡性结肠炎发展的分子机制研究,30万,2024.01-2026.12,在研。

3. 山东省自然科学基金青年项目,ZR2023QH427,基于蛋白磷酸酶PPM1B的急性B淋巴细胞白血病治疗新靶标的发现, 2024.01-2026.1215万,在研。

4. 山东省高等学校 “ 青创团队计划 ”, 2022KJ197, 参麦注射液抗新冠肺炎危重症感染的活性成分及分子机制研究,2023.01-2025.1230 万,结题。

5. 山东省医药卫生科技发展计划项目-青年项目,Q-2023107,党参碳量子点的制备、表征及在贫血治疗中的应用,2023.08-2025.07万,结题。

6. 广东省重点实验室开放课题,5万,2024.01-2025.12,结题

7. 山东第一医科大学高层次人才引进经费资助项目,2022.07-2027.06200万,在研。


近五年代表性论文(限第一作者和通讯作者):

1. Zhiyuan Lu#, Lixia Huang#, Yanxia Li, et al. Fine-tuning of cholesterol homeostasis controls erythroid differentiation. Advanced Science. 2021,2102669:1-17. (1, IF: 17.52)

2. Zhiyuan Lu, Hanzhi Yu, Yanxia Li, et al. Phosphatase, Mg2+/Mn2+ Dependent 1B regulates the hematopoietic stem cells homeostasis via the Wnt/-catenin signaling. Haematologica.2023, 109( 7) : 2144-2156. (1, IF: 10.1)

3. Teng Liu, Yang Wu, Chun Wang, Tiantian Zhou, Rongzhen Yang, Xu Zhang, Wenli Yan, Qing Fan*, Zhiyuan Lu*. Mulberry-derived Carbon Dots Attenuate Kidney Fibrosis through Direct Inhibition of PI3K. Materials Today Bio. 2025,102626.(1区, IF: 10.2)

4. Xiang Li#, Yanjiao Ding#, Jingwen Xue#, Yinxue Fu, Fang Yan, Nannan Song, Honggang Hu, Wei Cong*, Zhiyuan Lu*, Yulei Li*. Peptide Double-Stapling and Arginine N-Glycosylation Triggered the Development of Therapeutic Antimicrobial Peptides Capable of Killing Drug-Resistant Bacteria in Mice. Journal of Medicinal Chemistry. 2025, 68(4): 4511-4526. (1, IF: 6.8)

5. Zhiyuan Lu*, Haojia Li, Nannan Song, Zhiwei Wang, Hua Wang, Asma Rehman, Liwen Han, Ke-Wu Zeng*. Therapeutic Potential of Carbon Dots Derived from Phytochemicals as Nanozymes Exhibiting Superoxide Dismutase Activity for Anemia. ACS Appl Mater Interfaces. 2025;17(3):4562-4578. (2, IF: 8.6)

6. Zhi-Fang Liu, Jiang-Hui Wang, Cheng-Peng Wang, Qi Wang, Jian Li, Chen-Jing Han, Zhi-Yuan Lu*. Green hydrothermal valorization of Rosa damascena Mill. floral waste into functional carbon dots for anti-inflammatory nanomedicine. Industrial Crops and Products, 2025, 236, 122115.  (1区, IF: 6.2)

7. Chonglei Zhong#, Nannan Song#, Ping Huang, Liwen Han, Kewu Zeng, Jiguo Zhang*, Zhiyuan Lu*, Lei Wang*. Targeting ROS and Inflammation in Sepsis-Induced Liver Injury with Naturally Derived Superoxide Dismutase-Mimicking Carbon Dots. Biomaterials Research. 2025,29:0249. (2区, IF: 9.60)

8. Zhiyuan Lu#, Guangsen Xu#, Yanxia Li#, et al. Discovery of N-arylcinnamamides as Novel Erythroblast Enucleation Inducers. Bioorganic Chemistry. 2022, 128:106105. (1, IF: 5.30)

9. Lei Wang#, Zhong-Yao Li#, Chong-Lei Zhong#, Zi-Yang Teng, Bin Wang, Asma Rehman, Li-Wen Han, Ke-Wu Zeng*, Ji-Guo Zhang*, Zhi-Yuan Lu*. Therapeutic potential of naturally derived carbon dots in sepsis-associated acute kidney injury. Chinese medicine. 2025,20(1):49. (2, IF: 5.30)

10. Lingmei Li#, Shuwan Li#, Lin Gao#, Sitong Chen, Dejin Zang, Qing Fan*, Zhiyuan Lu*, Teng Liu*. A GSH-responsive drug delivery system based on self-assembly of polyoxometalates modified camptothecin for chemotherapy. Materials Today Advances, 2026, 29, 100679. (2, IF: 8.0)

地址:山东省济南市槐荫区青岛路6699号

电话:0531-59567288 邮箱:yxy@sdfmu.edu.cn

版权:山东第一医科大学药学院(药物研究所)